Barbara Ryan | Investor Relations Officer |
Robert Ward | Chairman and Chief Executive Officer |
Matthew Goddeeris | Senior Principal Scientist |
Greg Williams | our Chief Operating Officer |
Greg Weaver | Chief Financial Officer |
Shawn Egan | Citi |
Frank Atkins | SunTrust Robinson Humphrey |
Ben Shim | Canaccord |
Good morning, everyone, and welcome to Eloxx Pharmaceuticals Third Quarter 2018 Earnings Webcast and Conference Call. Today’s call is being recorded. At this time, I would like turn the call over to Barbara Ryan, Eloxx’s Investor Relations Officer. Please begin.
Thank you, Liz.